BAX Stock Analysis: Buy, Sell, or Hold?
BAX - Baxter International Inc.
$26.16
-0.59 (-2.21%)
▼
5d:
+16.79%
30d:
+20.61%
90d:
+48.81%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Smart Money Accumulation
None View Scanner →
Strength: 6.1/10
Get Alerted When BAX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: BAX is 9.1% above its trading range ($23.98). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: BAX is 9.1% above its trading range ($23.98). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$21.55
Based on 2.8% avg growth
INTRINSIC VALUE TODAY
$13.38
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BAX is currently trading at $26.16, which is considered extended relative to its 30-day fair value range of $21.02 to $23.98. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.9) compared to its historical average (9.3). At these levels, the market is pricing in 11.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, BAX is in a strong uptrend. Immediate support is located at $21.40, while resistance sits at $30.00.
Market Sentiment: BAX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BAX is in a strong uptrend. Immediate support is located at $21.40, while resistance sits at $30.00.
Market Sentiment: BAX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$21.02 -
$23.98
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
Protect Your Profits
BAX is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+9.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($24.38)
- NEUTRAL: PE elevated vs history but 11.6% growth expectation is conservative given 238% recent growth
Trading Range Analysis
30-Day Trading Range
$21.02 -
$23.98
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$21.40
Resistance Level
$30.00
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.93
Wall Street Target
$24.38
(-6.8%)
Revenue Growth (YoY)
2.9%
Earnings Growth (YoY)
237.9%
Profit Margin
-9.7%
Valuation Premium vs History
+11.6% premium
PE vs Historical
12.9 vs 9.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.6%
(market-implied from PE analysis)
1-Year Target
$29.19
(+12%)
2-Year Target
$32.58
(+25%)
3-Year Target
$36.36
(+39%)
3-Yr Target (if PE normalizes)
(PE: 13→9)
PE COMPRESSION
$26.16
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 1.5%)
$43.84
(+68%)
Base:
(SPY PE: 12.9, Growth: 1.5%)
$27.34
(+5%)
Bear:
(PE: 9.3, Growth: 1.5%)
$19.67
(-25%)
Share & Embed Analysis
Last updated: August 02, 2026 10:19 AM ET
Data refreshes hourly during market hours. Next update: 11:19 AM
Data refreshes hourly during market hours. Next update: 11:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BAX showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
NEUTRAL
Recent Transactions
Michael T. McCaul
BUY
2026-02-17
Ro Khanna
BUY
2026-02-17
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$477 | 47 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$87 | 50 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 50 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 56 HOLD |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$15 | 56 HOLD |
Advanced BAX Option Strategies
Professional options setups generated by AI based on today's BAX price and gamma walls.
